Prof. Chan Wai-yee, Pro-Vice-Chancellor/Vice-President of The Chinese University of Hong Kong (CUHK) and Director of the School of Biomedical Sciences (SBS), together with Prof. Christopher H.K. Cheng, Managing Director of Hong Kong Institute of Biotechnology Limited (HKIB) and Research Professor of SBS, officiated at the Opening Ceremony of “GMP Product Development and Technical Support Platform for Traditional Oral Solid Proprietary Chinese Medicine Products” (The Project) on 7 May 2019.
This 3-year project was launched by HKIB, a wholly-owned subsidiary of CUHK in 2015, with the generous support of the Innovation and Technology Fund and the donation from The Hong Kong Jockey Club Charities Trust. The Project aims at generating a platform to provide support for oral solid dosage pharmaceutical traditional Chinese medicinal products to comply with GMP requirements.
The related coverage by Communications and Public Relations Office can be viewed HERE.
(From left) Prof. Chan Wai-yee, Ms. Annie Choi, Commissioner for Innovation and Technology, Ms. Jasmine Chung, Executive Manager, Charities (Grant Making – Rehabilitation and Medical), The Hong Kong Jockey Club, and Prof. Christopher Cheng officiate at the Opening Ceremony
Prof. Chan Wai-yee delivers a welcome speech
Prof. Christopher Cheng delivers a closing remarks
(From right) Mr. Tommy Y.S. Li, Chief President of Hong Kong Chinese Medicine Industry Association, Prof. Christopher Cheng, Ms. Jasmine Chung, Prof. Chan Wai-yee and Ms. Annie Choi
